Skip to main content
. 2022 Jul 15;22(18):2200118. doi: 10.1002/pmic.202200118

FIGURE 2.

FIGURE 2

Experimental workflow for metabolomic characterization of COVID‐19 patient CCP. Plasma is harvested from a cohort of recovered COVID‐19 patients (CCP donors), CCP treated COVID‐19 survivors, and healthy controls. The plasma metabolomes are analysed using mass spectrometry. The metabolomic profiles coupled with clinical patient information can be used to identify COVID‐19‐associated molecules, pathways, and biomarkers